VGene

Fully human therapeutic antibodies discovered faster, cheaper, and deeper for direct license to pharma partners.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Seattle, WA, USA
  • Currency USD
  • Founded January 2012
  • Employees 2
  • Website vgene.biz

Company Summary

By using our proprietary platform, V-Genesis, antibodies that already exist within us where they are known to be safe and efficacious are now easily recovered, assayed in vitro, and molecularly reconstituted as fully human recombinant antibodies for out license to pharmas/biotech companies who wish to develop them. Our approach allows the rapid selection of the best possible antibody while dramatically lowering risk of drug failure.

Team

  • Johnny T. Stine
    Co-founder

    Co-founder of V-Gene Inc.
    Founder of North Coast Biologics,LLC
    Founder of Theraclone-Sciences (aka Spaltudaq)
    All endeavors involve therapeutic and diagnostic antibody discovery. Currently have 2 antibodies in clinical trials, responsible for several pharma partnerships totaling over $650M. I've raised a total of $34M in venture funding and $1M in biotech partner money via North Coast Biologics.

  • Steven R. Wiley
    Co-founder

    Co-founder of VGene Inc.
    Founder of ImDaptive Inc.
    Co-founder of VLST Inc.
    Steve has developed technology for drug discovery in immune-modulation and deep sequencing algorithms for profiling the adaptive immune response as well as numerous other discoveries during his 18 years of working at pharmaceutical and biotechnology companies. Responsible for raising $55M in venture funding along with corporate partnership funding totaling $12M.

  • Johnny Stine

Advisors

  • Jim Johnston
    Lawyer
    Unconfirmed

Previous Investors

  • Canaan Ventures
    Unconfirmed
    Health Care Ventures
    Unconfirmed
    MPM Capital
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free